Vanderbilt-Ingram Cancer Center (VUMC) is a leader in integrated, patient-focused cancer care and innovation, recognized as one of 51 National Cancer Institute-designated Comprehensive Cancer Centers. Our mission is to harness scientific discovery to deliver cutting-edge treatments and improve quality of life for patients and their families.

We drive advancements through extensive research programs spanning breast, gastrointestinal, and genome maintenance, including specialized efforts like the SPOREs. As a key partner in discovery, we conduct clinical trials and lead international studies, notably in rare blood cancers like MDS/MPN overlap syndrome. Our dedication to excellence has earned exceptional scores for research impact and patient care. Join us in the pursuit of tomorrow's cancer treatments.